LLY

758.39

+1.65%↑

UNH

510.99

-5.87%↓

JNJ

147.95

+2.22%↑

ABBV

173.7

+1.54%↑

NVO

83.25

+0.37%↑

LLY

758.39

+1.65%↑

UNH

510.99

-5.87%↓

JNJ

147.95

+2.22%↑

ABBV

173.7

+1.54%↑

NVO

83.25

+0.37%↑

LLY

758.39

+1.65%↑

UNH

510.99

-5.87%↓

JNJ

147.95

+2.22%↑

ABBV

173.7

+1.54%↑

NVO

83.25

+0.37%↑

LLY

758.39

+1.65%↑

UNH

510.99

-5.87%↓

JNJ

147.95

+2.22%↑

ABBV

173.7

+1.54%↑

NVO

83.25

+0.37%↑

LLY

758.39

+1.65%↑

UNH

510.99

-5.87%↓

JNJ

147.95

+2.22%↑

ABBV

173.7

+1.54%↑

NVO

83.25

+0.37%↑

Search

Bio-Techne Corp

Cerrado

Sector Salud

72.99 -2.76

Resumen

Variación precio

24h

Actual

Mínimo

72.92

Máximo

73.75

Métricas clave

By Trading Economics

Ingresos

-7M

34M

Ventas

-17M

290M

P/B

Media del Sector

57.32

59.974

BPA

0.42

Rentabilidad por dividendo

0.4

Margen de beneficio

11.606

EBITDA

8.9M

81M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+13.9 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.40%

2.29%

Próximas Ganancias

30 ene 2025

Fecha Próximo Dividendo

24 feb 2025

Próxima Fecha de Ex Dividendo

7 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-20M

11B

Apertura anterior

75.75

Cierre anterior

72.99

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

169 / 392 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Bio-Techne Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

10 ene 2025, 21:00 UTC

Principales Movimientos del Mercado

Shares of Mercury General, Lemonade, Other Insurers Fall in Wake of California Wildfires

10 ene 2025, 17:57 UTC

Adquisiciones, fusiones, absorciones

EU Competition Regulator Conditionally Clears Synopsys' $35 Billion Ansys Deal

10 ene 2025, 22:43 UTC

Principales Noticias

Judge Rules American Airlines Violated Retirement-Plan Duties by Encouraging ESG Investing -- WSJ

10 ene 2025, 22:21 UTC

Principales Noticias

Apple CEO Tim Cook's 2024 Pay Rises 18% to $74.6M

10 ene 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 ene 2025, 21:46 UTC

Principales Noticias

Employers Added 256,000 Jobs in December, and Unemployment Slips to 4.1% -- 6th Update

10 ene 2025, 21:22 UTC

Ganancias

These Stocks Moved the Most Today: Walgreens, Delta, Nvidia, AMD, Constellation Energy, Allstate, Mercury General, Constellation Brands, and More -- Barrons.com

10 ene 2025, 21:21 UTC

Principales Noticias

U.S. Stock Indexes Slide, Bond Yields Jump After Jobs Report -- WSJ

10 ene 2025, 21:18 UTC

Ganancias

Tesla's Model Y Gets an Update in China. What It Means for the Stock. -- Barrons.com

10 ene 2025, 20:26 UTC

Charlas de Mercado

U.S. Natural Gas Extends Gains on Weather Outlook -- Market Talk

10 ene 2025, 20:11 UTC

Charlas de Mercado

Crude Futures Gain on U.S. Sanctions, Winter Demand -- Market Talk

10 ene 2025, 19:45 UTC

Charlas de Mercado

Canada's Rig Count Rises By 122 in Seasonal Jump -- Market Talk

10 ene 2025, 19:36 UTC

Ganancias

Nvidia Is Poised to Conquer Personal Computing Next. Chip Makers Should Be Nervous. -- Barrons.com

10 ene 2025, 19:28 UTC

Principales Noticias

U.S. Stock Indexes Slip After Jobs Report Dampens Rate-Cut Hopes -- WSJ

10 ene 2025, 19:23 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Disney, Fox and Warner Won't Move Forward With Venu Sports -- 4th Update

10 ene 2025, 19:10 UTC

Principales Noticias

Disney, Fox and Warner Won't Move Forward With Venu Sports -- 3rd Update

10 ene 2025, 19:09 UTC

Ganancias

These Stocks Are Moving the Most Today: Walgreens, Delta, Nvidia, AMD, Constellation Energy, Allstate, Mercury General, Constellation Brands, and More -- Barrons.com

10 ene 2025, 18:55 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By Two to 480 -- Market Talk

10 ene 2025, 18:44 UTC

Charlas de Mercado

Retaliatory Tariffs From Canada Threaten to Heighten Country's Economic Pain -- Market Talk

10 ene 2025, 18:17 UTC

Adquisiciones, fusiones, absorciones

Synopsys Responds To The European Commission Approving Its Proposed Acquisition Of Ansys In Phase 1 >SNPS

10 ene 2025, 18:16 UTC

Adquisiciones, fusiones, absorciones

Paysafe Stock Could More Than Double. The Case for an Acquisition. -- Barrons.com

10 ene 2025, 18:13 UTC

Principales Noticias

Power Giant Strikes While the Iron is Hot -- Heard on the Street -- WSJ

10 ene 2025, 17:53 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 ene 2025, 17:53 UTC

Charlas de Mercado

Canada's Outsize Job Gain Shows Limited Momentum in Private Sector -- Market Talk

10 ene 2025, 17:49 UTC

Ganancias

These Stocks Are Moving the Most Today: Walgreens, Delta, Nvidia, AMD, Constellation Energy, Allstate, Mercury General, Constellation Brands, and More -- Barrons.com

10 ene 2025, 17:35 UTC

Charlas de Mercado

Time to 'Can The Talk' About Canada's Weak Labor Market -- Market Talk

10 ene 2025, 17:30 UTC

Adquisiciones, fusiones, absorciones

EU Competition Regulator Conditionally Clears Synopsys' $35 Billion Ansys Deal

10 ene 2025, 17:30 UTC

Adquisiciones, fusiones, absorciones

European Commission Approves Synopsys Ansys Deal With Concessions

10 ene 2025, 17:30 UTC

Adquisiciones, fusiones, absorciones

EU Gives Synopsys Ansys Merger Green Light With Remedies

10 ene 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Bio-Techne Corp Esperado

Precio Objetivo

By TipRanks

13.9% repunte

Estimación a 12 meses

Media 83.5 USD  13.9%

Máximo 95 USD

Mínimo 75 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bio-Techne Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

4

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

72.98 / 75.19Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

169 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.